Zentalis Pharmaceuticals shares owned by T. Rowe Price Investment Management
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by T. Rowe Price Investment Management
from 13F filings
Historical chart of T. Rowe Price Investment Management investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Zentalis Pharmaceuticals by T. Rowe Price Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $52M | 3.3M | 15.76 |
2023-09-30 | $40M | 2.0M | 20.06 |
2023-06-30 | $56M | 2.0M | 28.21 |
2023-03-31 | $35M | 2.0M | 17.20 |
2022-12-31 | $45M | 2.2M | 20.14 |
More positions owned by T. Rowe Price Investment Management
View all positions for T. Rowe Price Investment Management